Relation of the total ejection isovolume index to symptoms in aortic stenosis

Abstract

1. Borghi C, Boschi S, Ambrosioni E, Melandri G, Branzi A, Magnani B. Evidence of a partial escape of renin-angiotensin-aldosterone blockade in patients with acute myocardial infarction treated with ACE inhibitors. J Clin Pharmacol 1993;33:40–45. 2. Struthers AD. Aldosterone escape during angiotensin converting enzyme inhibitor therapy in chronic heart failure. J Card Fail 1996;2:47–54. 3. van Vilet A, Donker AJM, Nauta JJP, Verhengt FWA. Spironolactone in congestive heart failure refractory to high dose loop diuretic and low dose angiotensin-converting enzyme inhibitor. Am J Cardiol 1993;71:21A–28A. 4. Pitt B, Zannad F, Remme WJ, Cody R, Castaigne A, Perez A, Palensky J, Wittes J. The effect of spironolactone on morbidity and mortality in patients with severe heart failure. N Engl J Med 1999;341:709–717. 5. Berry C, McMurray JJ. Serious adverse events experienced by patients with chronic heart failure taking spironolactone. Heart 2001;85:E8. 6. Vanpee D, Swine CH. Elderly heart failure patients with drug-induced serious hyperkalemia. Aging (Milano) 2000;12:315–319. 7. Schepkens H, Vanholder R, Billiouw J, Lameire N. Life-threatening hyperkelemia during combined therapy with angiotensin-converting enzyme inhibitors and spironolactone: an analysis of 25 cases. Am J Med 2001;110:438–441. 8. Beck LH. The aging kidney. Defending a delicate balance of fluid and electrolytes. Geriatrics 2000;55:26–28; 31–32. 9. Cockcroft DW, Gault MH. Prediction of creatinine clearance from serum creatinine. Nephron 1976;16:31–41. 10. Fliser D, Franek E, Joest M, Block S, Mutschler E, Ritz E. Renal function in the elderly: impact of hypertension and cardiac function. Kidney Int 1997;51: 1196–1204. 11. Bauer JH. Age-related changes in the renin-aldosterone system. Physiological effects and clinical implications. Drugs Aging 1993;3:238–245. 12. Flood C, Gherondache C, Pincus G, Tait JF, Tait SA, Willoughby S. The metabolism and secretion of aldosterone in elderly subjects. J Clin Invest 1967; 46:961–966. 13. Schlondorff D. Renal complications of nonsteroidal anti-inflammatory drugs. Kidney Int 1993;44:643–653. 14. Stichtenoth DO, Frolich JC. Cox-2 and the kidneys. Curr Pharm Des 2000;6:1737–1753.